Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis

Background & Aims: We have shown previously that mycophenolate mofetil (MMF) might be used as first-line treatment instead of azathioprine (AZA) in individuals with autoimmune hepatitis (AIH). Herein, we present our long-term prospective data on response and outcome after first-line therapy...

Full description

Bibliographic Details

Published in:	JHEP Reports
Main Authors:	George N. Dalekos, Pinelopi Arvaniti, Nikolaos K. Gatselis, Stella Gabeta, Anna Samakidou, George Giannoulis, Eirini Rigopoulou, George K. Koukoulis, Kalliopi Zachou
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Subjects:	Autoimmune hepatitis Mycophenolate mofetil Azathioprine Outcome Survival
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555922001732